Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt

Clinical trial NCT05813496 · COMPLETED

Trial details

NCT number: NCT05813496
Sponsor: Eva Pharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Polyneuropathy, Diabetic

Start date: 2022-10-26
Primary completion: 2024-08-03
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.